BACKGROUND
Petrelintide is a novel, long-acting amylin analogue being developed for long-term treatment of obesity, leveraging a mechanism of action distinct from incretin-based treatments. This phase 2 trial aimed to evaluate the efficacy and safety of once-weekly petrelintide versus placebo in people with obesity....
W. T. Garvey, J. Ard, L. Connery et al.· The Lancet Diabetes and Endo...· 1 citation
BACKGROUND
For persons living with both type 2 diabetes and obesity, weight management may be the most effective therapy for type 2 diabetes. Glucagon-like peptide-1 (GLP-1) receptor agonists have potent weight-reducing effects, and other mechanisms may confer additional benefits. Survodutide is an investigational gluc...
Sean Wharton, C. L. le Roux, E. Startseva et al.· New England Journal of Medic...· 0 citations
Abstract DXA and HR-pQCT are used for bone assessment but also image adjacent soft tissue. This pilot study examined association between HR-pQCT-measured leg muscle cross-sectional area (CSA) and density vs DXA-derived lean mass, and explored associations with muscle strength, power, and physical performance in adults...
Søren Gam, Joshua R. Stapleton, Vivian Jing et al.· JBMR Plus· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.